BioSpace News Archive

Drug Development

Actinium Presents New Pivotal Phase 3 SIERRA Trial Data Showing Rapid Peripheral Blast Reduction and Anti-Leukemic Effect with Single Agent Iomab-B in Older Patients with Active, Relapsed or Refractory Acute Myeloid Leukemia at 2019 ASCO

Lower circulating leukemia tumor burden achieved prior to bone marrow transplant with single agent Iomab-B with 98% peripheral blast reduction by day 3 and 100% peripheral blast reduction by day 8

June 4, 2019
·
9 min read
Deals

Advaxis to Host Business Update Conference Call on June 11, 2019

Advaxis, Inc., a late-stage biotechnology company focused on the discovery, development and commercialization of immunotherapy products, announces that the company will host a business update call on Tuesday, June 11, 2019 at 11:00 a.m. ET.

June 4, 2019
·
4 min read
Horizon Therapeutics plc to Participate in the JMP Securities Life Sciences Conference

Horizon Therapeutics plc, announced that the company will participate in the following conference in June

June 4, 2019
·
1 min read
Business

Apyx Medical Corporation to Participate in the JMP Securities Life Sciences Conference

JMP Securities Life Sciences Conference at the St. Regis New York Hotel in New York, NY. Management will participate in a fireside chat on Thursday, June 20 at 1:00 p.m. Eastern Time.

June 4, 2019
·
2 min read
Business

Re-Vana Therapeutics Names Renowned International Experts to Inaugural Scientific Advisory Board

New International Team Brings Extensive Ocular Drug Delivery and Scientific Expertise to Advance the Sustained Release of Biologics and Small Molecules into the Eye to Treat Sight-Threatening Eye Diseases

June 4, 2019
·
5 min read
Job Trends

Upcoming Pharm-Olam Webinar Helps Sponsors Manage Rescue Study Transitions

Pharm-Olam, a global, midsized CRO offering full-service clinical development solutions for oncology-hematology, infectious diseases and vaccines and rare diseases, will be sharing key strategies for pharmaceutical companies needing to transition studies to a different CRO in a free webinar on June 18.

June 4, 2019
·
2 min read
Genetown

Strand Therapeutics Announces $6 Million Seed Financing to Advance its Programmable mRNA Therapeutics Platform

Seed round led by Playground Global to focus on the advancement of next-generation mRNA-based cancer immunotherapies and development of its proprietary synthetic biology platform

June 4, 2019
·
4 min read
Job Trends

Asuragen NGS System Streamlines Detection of NSCLC-associated DNA Mutations, Gene Fusions, and RNA Expression Targets in Single Workflow

The targeted NGS panel enables the detection of 135 RNA and 55 DNA variants associated with non-small cell lung cancer

June 4, 2019
·
3 min read
Business

Applied DNA and Integrated Supply Chain Partners Scale Up to Provide Global Material Traceability for Companies Declaring “2020” Sustainability Goals

CertainT Platform Provides Evidence of Recycled Polyester Filament and Fiber Content Claims in Asia, Americas and EMEA

June 4, 2019
·
7 min read
Genetown

Vertex to Present Data at ECFS Conference on Potential Impact of Early Treatment and Long-Term Treatment with CFTR Modulators on the Underlying Cause of CF

Vertex Pharmaceuticals Incorporated announced that data from six scientific abstracts from the company’s portfolio of cystic fibrosis medicines will be presented at the 42nd European Cystic Fibrosis Conference, taking place June 5-8, 2019 in Liverpool, UK.

June 4, 2019
·
16 min read